Exelixis
EXEL
#1684
Rank
โ‚ฌ9.43 B
Marketcap
33,04ย โ‚ฌ
Share price
3.04%
Change (1 day)
60.38%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: โ‚ฌ9.43 Billion

As of January 2025 Exelixis has a market cap of โ‚ฌ9.43 Billion. This makes Exelixis the world's 1684th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ9.43 B1.68%
2024โ‚ฌ9.27 B37.49%
2023โ‚ฌ6.74 B39.91%
2022โ‚ฌ4.82 B-5.56%
2021โ‚ฌ5.10 B0.88%
2020โ‚ฌ5.06 B5.92%
2019โ‚ฌ4.77 B-7.31%
2018โ‚ฌ5.15 B-31.21%
2017โ‚ฌ7.49 B82.4%
2016โ‚ฌ4.10 B249.5%
2015โ‚ฌ1.17 B406.97%
2014โ‚ฌ0.23 B-71.68%
2013โ‚ฌ0.81 B29.06%
2012โ‚ฌ0.63 B28.4%
2011โ‚ฌ0.49 B-26.73%
2010โ‚ฌ0.67 B21.51%
2009โ‚ฌ0.55 B46.4%
2008โ‚ฌ0.37 B-38.75%
2007โ‚ฌ0.61 B-5.44%
2006โ‚ฌ0.65 B-1.28%
2005โ‚ฌ0.66 B26.28%
2004โ‚ฌ0.52 B31.56%
2003โ‚ฌ0.39 B-12.16%
2002โ‚ฌ0.45 B-56.99%
2001โ‚ฌ1.05 B45.65%
2000โ‚ฌ0.72 B

End of Day market cap according to different sources

On Jan 7th, 2025 the market cap of Exelixis was reported to be:

โ‚ฌ9.43 Billion
by Nasdaq info icon info icon
โ‚ฌ9.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ67.16 B 611.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ120.74 B 1,179.81%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ246.77 B 2,515.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ111.91 B 1,086.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ136.03 B 1,341.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ339.99 B 3,503.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ148.47 B 1,473.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.49 M-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.50 B-94.66%๐Ÿ‡บ๐Ÿ‡ธ USA